BNP/CALL/BRISTOL-MYERS SQUIBB/50/0.1/17.01.25 Stock BNP/CALL/BRISTOL-MYERS SQUIBB/50/0.1/17.01.25
Add to a list
To use this feature you must be a member
Log inSign up

BNP/CALL/BRISTOL-MYERS SQUIBB/50/0.1/17.01.25 Share Price

Warrant

DE000PN8YZY5

Market Closed - Deutsche Boerse AG 20:50:31 28/06/2024 BST
0.088 EUR -2.22% Intraday chart for BNP/CALL/BRISTOL-MYERS SQUIBB/50/0.1/17.01.25
Current month-2.22%
1 month+25.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart BNP/CALL/BRISTOL-MYERS SQUIBB/50/0.1/17.01.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/06/24 0.088 -2.22%
27/06/24 0.09 -18.18%
26/06/24 0.11 0.00%
25/06/24 0.11 0.00%
24/06/24 0.11 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN8YZY
ISINDE000PN8YZY5
Date issued 28/09/2023
Strike 50 $
Maturity 17/01/2025 (201 Days)
Parity 10 : 1
Emission price 1.13 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.13 €
Lowest since issue 0.063 €
Delta0.21x
Omega 8.814
Premium22.77x
Gearing42.15x
Moneyness 0.8306
Difference Strike 8.47 $
Difference Strike %+16.94%
Spread 0.01 €
Spread %10.31%
Intrinsic value 0.000000

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53 USD
Average target price
53.19 USD
Spread / Average Target
+28.09%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant